The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> March 10, 2017

Interview with the President, CEO and Director: Critical Outcome Technologies, Inc. (CVE:COT)

Silva, Alison
Alison Silva, M.A., is the President, Chief Executive Officer and Director of Critical Outcome Technologies, Inc. Previously, she was a Co-Founder, Executive Vice President and Chief Operating Officer at Synlogic, Inc., where she lead the regulatory strategy, drug development and operational aspects of the company’s focus on the discovery and development of engineered therapeutic probiotics. Ms. Silva is also a Co‐Founder of The Orphan Group, a specialty consulting company focused on assisting companies with developing and implementing their orphan drug strategy and product lifecycle management. Ms. Silva previously held the position of Chief Operating Officer at SLA Pharma, a GI‐oncology-focused biotech company, where she was responsible for heading up U.S. corporate and clinical operations for their pipeline of orphan drug candidates. Prior to joining SLA Pharma, Ms. Silva was Vice President of Drug Development at Marina Biotech through its acquisition of Cequent Pharmaceuticals in 2010, where she held the same role since 2007. Ms. Silva began her career in drug development in clinical operations with various positions at Pfizer, Massachusetts General Hospital and the University of Massachusetts. Ms. Silva holds a bachelor’s degree from Clark University, and a master’s degree from Clark University and UMass Medical Center. Profile
TWST: What is Critical Outcome Technologies today?

Ms. Silva: We are a clinical-stage biotech company that uses a proprietary technology platform to identify drugs

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)
Interview with the Founder and Executive Chairman: Organovo Holdings Inc. (NASDAQ:ONVO)
Interview with the Co-Founder and CEO: Equillium Inc. (NASDAQ:EQ)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Electric Cars and AI Fuel Long-Term Electricity Demand
Separating the Real Winners and Losers in the AI Boom
Generating Dividend Yield That’s Not Correlated to Interest Rates
ANALYST INTERVIEWS
Robust M&A Activity Provides Tailwind to Biotech Sector
Seeking Out Game Changers in Re-Emerging Biotech Sector
Obesity Drugmakers Still a ‘Buy’ Despite Lofty Valuations
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy